Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services' subsidiary, Optival Health Solutions Private Limited, received a suspension order for the drug license of its store located opposite the Private Bus Stand, Baragarh, Odisha. The order was issued by the Deputy Drugs Controller, Western Zone, Sambalpur, and received on March 9, 2026, under Rule 65 of the Drugs and Cosmetics Act, 1940. The suspension is for a period of three days. The company has disclosed a potential revenue loss of approximately Rs 1.38 lacs from this action.
This is a minor, routine regulatory action affecting a single store with negligible financial impact (Rs 1.38 lacs) relative to Medplus's overall operations. Unlikely to have any material effect on the stock price or business outlook.